NCT04972162 is a NA clinical trial of Web App Strategy Fitting in Hearing Loss, Sensorineural, sponsored by WSAUD A/S.

Who is sponsoring NCT04972162?

NCT04972162 is sponsored by WSAUD A/S.

What drugs are being tested in NCT04972162?

Interventions in NCT04972162: Web App Strategy Fitting, Standard-of-care Fitting.

What condition does NCT04972162 study?

NCT04972162 studies Hearing Loss, Sensorineural.

Is NCT04972162 still recruiting?

NCT04972162 is currently completed. Last updated 30 September 2025.

Are results published for NCT04972162?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2025-09-30 · How we verify

NCT04972162

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fitting Strategy Study

Completed NA Results posted Last updated 30 September 2025

What this trial tests

NA trial testing Web App Strategy Fitting in Hearing Loss, Sensorineural in 28 participants. Completed in 12 November 2021.

Timeline

26 July 2021

Primary endpoint
12 November 2021

12 November 2021

Quick facts

Lead sponsor	WSAUD A/S
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	treatment
Enrollment	28
Start date	26 July 2021
Primary completion	12 November 2021
Estimated completion	12 November 2021
Sites	1 location across United States

Drugs / interventions tested

Web App Strategy Fitting
Standard-of-care Fitting

Conditions studied

Hearing Loss, Sensorineural — all drugs for Hearing Loss, Sensorineural →

Sponsor

WSAUD A/S — full company profile →

Who can join

18 and older, any sex, with Hearing Loss, Sensorineural. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Abbreviated Profile of Hearing Aid Benefit (APHAB) Primary · 14-17 Days hearing aid wearing time per fitting type

The APHAB consists of 24 questions across 4 subscales: Ease of Communication (EC), Background Noise (BN), Reverberation (RV), and Aversiveness (AV), assessing hearing difficulties in daily situations reported as percentage of problems (0-100%, 100% = highest number of problems). It evaluates hearing aid (HA) benefit by subtracting the reported % of problems with HA from without HA, yielding scores from 0 (no benefit) to 100 (maximum benefit) in each subscale. The study focuses on the communication subscales (EC, BN, RV) and calculates benefit score differences for each subscale after using A)

Benefit Ease of Communication

Group	Value	95% CI
Web-App-fitted Hearing Aids	12.7	± 19.09
Standard-of-care-fitted Hearing Aids	13.18	± 13.60

Benefit Background Noise

Group	Value	95% CI
Web-App-fitted Hearing Aids	11.17	± 22.98
Standard-of-care-fitted Hearing Aids	12.22	± 19.94

Benefit Reverberant Room

Group	Value	95% CI
Web-App-fitted Hearing Aids	11.43	± 22.32
Standard-of-care-fitted Hearing Aids	12.49	± 16.76

Sponsor's own description

To be conducted with adult participants with mild-to-moderate hearing loss to validate the effectiveness of the Web App fitting strategy. Validation measures participant's perceived hearing aid benefit when using the Web App fitted hearing aids and when using standard-of-care fitted hearing aids.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hearing Loss, Sensorineural

Currently open trials in the same condition.

NCT06499805 — Barriers and Facilitators to OTC Hearing Aids Success · NA · recruiting
NCT06560918 — Self-efficacy-based Auditory Rehabilitation With Over-the-Counter Hearing Aids · NA · recruiting
NCT06882889 — Comparing the Efficacy of Domestic Versus Imported Hearing Aids in ARHL · NA · recruiting
NCT06664697 — Post-Market Clinical Investigation of the IotaSOFT Insertion System · recruiting
NCT06268340 — Hearing and Structure Preservation Via ECochG · NA · recruiting

Other WSAUD A/S trials

Trials by the same sponsor.

NCT06986499 — Standard Post Market Clinical Follow-up (PMCF) Study WSA 2025 · NA · completed
NCT06700512 — Standard Post Market Clinical Follow-up (PMCF) Study WSA @ HZO · NA · completed
NCT05465564 — My Hearing Experience - a Study About the Effect of Personality and Lifestyle on Everyday Hearing · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04972162 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by WSAUD A/S
Last refreshed: 30 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04972162.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing